Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.29 +0.57%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of $0.12, $0.04 better than the analyst estimate of $0.08. Revenue for the quarter came in at $64.5 million versus the consensus estimate of $67.6 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
